Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics.
Novartis A G (NVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 6,763,132 | $753,954,045 | +238% | 0.33% |
| 2. | Renaissance Technologies Jim Simons | 2,287,251 | $254,982,741 | -15% | 0.39% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,432,775 | $159,725,757 | +1516% | 0.2% |
| 4. | Point72 Asset Management Steve Cohen | 1,082,375 | $120,663,112 | 0.28% | |
| 5. | Citadel Investment Group Ken Griffin | 1,067,586 | $119,014,487 | +82% | 0.02% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,755 | $1,664,492 | 0.05% | |
| 2. | 6,623 | $801,449 | 0.16% | |
| 3. | 4,936 | $597,268 | 0.08% | |
| 4. | 4,222 | $510,899 | 0.13% | |
| 5. | 3,793 | $458,990 | 0.07% |
News See All
11 Best European Stocks to Invest In
US stocks don’t always lead. That’s the sentiment echoed across the equity markets as investors increasingly eschew US stocks in favor of international names.
Novartis AG (NVS): A Bull Case Theory
We came across a bullish thesis on Novartis AG (NVS) on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on NVS.
Berenberg Bank Maintains a Hold Rating on Novartis (NVS)
Novartis AG (NYSE:NVS) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds.
Deutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PT
Novartis AG (NYSE:NVS) is one of the 10 Undervalued European Stocks to Invest in Now. Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NYSE:NVS) on June 9, setting a price...
10 Undervalued European Stocks To Invest In Now
On June 10, Carmine De Franco of BNP Paribas Asset Management appeared on CNBC to talk about the European market.
11 Best Drug Stocks to Buy According to Hedge Funds
Health and Human Services Secretary Robert F. Kennedy Jr.
Novartis' Pluvicto Shows Promise in Early Stage Prostate Cancer
On Monday, Novartis (NYSE:NVS) announced positive topline results from the Phase III PSMAddition trial, which showed that its targeted radioligand therapy/RLT, Pluvicto (lutetium (177Lu) vipivotide tetraxetan...
What Makes Novartis AG (NVS) a Differentiated Business?
Loomis Sayles, an investment management company, released its “Global Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript
Operator: Good morning and good afternoon, and welcome to the Novartis Q1 2025 Results Release Conference Call and Live Webcast.
Billionaire Hedge Funds
